Prospective observational study of SGLT2 inhibitor, tofogliflozin in patients with type 2 diabetes - Prospective observational study of tofogliflozin in patients with type 2 diabetes

agoya Medical Association0 个研究点目标入组 600 人开始时间: 2015年4月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•*Patients with type 2 diabetes
•*Age 20 years or older
•*The patients that diabetes treatment does not have a change more than the past two months
•* In more than 6.0% and regulation are less than +-10% of patients each HbA1c of most recent two times
•*Ability to give written informed consent

•*Patients with type 1 diabetes
•*History of severe ketosis, diabetic coma or previous coma within 6 months
•*Patients with severe infectious disease ,before or after surgery, or sever trauma
•*Occurrence of stroke, myocardial infarction or vascular complication required hospitalization within 6 months
•*Under treatment with SGLT-2 inhibitors
•*Pregnant, women on lactation or possibly pregnant women, or plan to pregnant during the study
•*History of hypersensitivity to tofogliflozin
•*Ineligible patients according to the investigator's judgment

发起方

agoya Medical Association